Japanese drinks giant Suntory Holdings said Monday it would buy the Lucozade and Ribena brands from British drugs firm GlaxoSmithKline for $2.1 billion. The deal, part of Suntory\'s bid to expand overseas to counter a shrinking domestic market, was expected to be completed by the end of the year, Suntory said.